HIV testing and injectable prevention for minibus drivers
Part of Infections clinical trials.
This study looks at ways to help minibus drivers get tested for HIV and use long-acting injectable medicine to prevent or treat HIV. It tests combining HIV self-testing with long-acting injectables to see if it improves health outcomes for drivers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a male commercial minibus driver.
- You must have been working as a driver for at least 6 months.
- You must be 18 years or older.
- You must be living in one of the study areas and plan to stay for the next 12 months.
- You must own a mobile phone.
- You must not already be known to be HIV positive.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different ways of taking HIV prevention medicine (PrEP) for men who travel for work in sub-Saharan Africa. It compares daily pills, pills only around sex, and a long-acting injectable to see which method works best and is easiest to use.
This study tests whether medical drones can safely deliver HIV medications and lab samples in remote areas. If successful, it could help people living with HIV get their medicine faster and more reliably.
This study tests whether giving at-home HIV and syphilis self-test kits to men who have sex with men (MSM) can help more people learn their status and get linked to care. It also looks at how sharing test results with partners might increase testing and prevent the spread of infections.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
This trial helps hospitals find undiagnosed HIV by improving testing and care. It supports healthcare teams to identify HIV in people with certain conditions and ensures those diagnosed get connected to treatment.
This study tests whether a long-acting injectable HIV medicine (given every couple of months) and teen support clubs can help adolescents stay healthy and engaged in care. If you are a teen living with HIV, this trial may offer a more convenient treatment option.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.